InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
3
T+90 hit rate
60%
T+90 mean return
-12.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Scannell Timothy J, Chief Operating Officer. Director active across 6 companies, notably INSULET CORP. In total, 16 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €2.3m. Activity tracked since 27 May 2021. The latest transaction was filed on 29 April 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
1,383 shares0Common StockSEC:0000937556-25-000073:0
5,000 shares@ US$225.8442.8% of flowCommon StockSEC:0001127602-24-023776:0
7,000 shares@ US$190.5151.7% of flowCommon StockSEC:0001127602-24-018360:0
964 shares@ US$23.8874100.0% of flowOrdinary SharesSEC:0001562180-24-004759:0
3,920 shares@ US$36.385.5% of flowCommon StockSEC:0001127602-24-016771:0
1,380 shares0Common StockSEC:0001127602-24-016464:0
5,694 shares0Common StockSEC:0001209191-23-054026:0
3,853 shares0Restricted Stock UnitsSEC:0001562180-23-005016:0
843 shares0Common StockSEC:0001127602-23-016719:0
1,009 shares0Common StockSEC:0001127602-22-015767:0
3,659 shares0Common StockSEC:0000310764-21-000115:0
3,659 shares0Common StockSEC:0000310764-21-000115
808 shares0Common StockSEC:0001127602-21-018313:0
808 shares0Common StockSEC:0001127602-21-018313
50,000 sharesCommon StockSEC:0000310764-16-000213:0
35,911 sharesCommon StockSEC:0000310764-16-000213:1
16 of 16 declarations
About Scannell Timothy J
Timothy J. Scannell serves as Director, President, and COO at Insulet Corp and Stryker Corp. He is responsible for the daily management and operational strategy of the companies. His expertise in the medical sector is essential for ensuring growth and operational efficiency.
